Delivery of NHS Commercial Learning & Development Centre of Excellence
NHS England · awarded 18 August 2025 · delivered in England
Who
| Buyer | NHS England Leeds |
|---|---|
| Supplier |
Moorhouse Consulting Limited |
| Category | services |
| Classification | E-learning services CPV 80420000 |
| Notice published | 11 September 2025 |
What it is for
The output of this contract will deliver specific curated learning and development modules aligned to the NHS Commercial Competency Framework (which was refreshed to align to the GCF and professional bodies competency frameworks (CILT, CIPS and SFIA) and includes clinical procurement, data and logistics). The delivery will support the creation of the NHS Commercial Learning and Development Centre of Excellence to which a full business case was submitted to and has agreed to be funded by Crown Commercial Services. The programme is a fully funded 3-year delivery programme to improve commercial capability and provide consistent, competent and relevant learning and development for the NHS workforce. These curated modules will form the learning library and training suite(s) for learners, will be owned and housed by the NHS on an NHS owned and managed platform, with the ability to offer out to the wider health family free of cost.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
1270 awards on file, worth £50.2bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
Everything NHS England has awarded →
Other contracts won by this supplier
28 awards on file, worth £11.1m.